Author:
Tagliafico E,Tenedini E,Manfredini R,Grande A,Ferrari F,Roncaglia E,Bicciato S,Zini R,Salati S,Bianchi E,Gemelli C,Montanari M,Vignudelli T,Zanocco-Marani T,Parenti S,Paolucci P,Martinelli G,Piccaluga P P,Baccarani M,Specchia G,Torelli U,Ferrari S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference45 articles.
1. Tallman MS . Acute promyelocytic leukemia as a paradigm for targeted therapy. Semin Hematol 2004; 41 (Suppl 4): 27–32.
2. Manfredini R, Trevisan F, Grande A, Tagliafico E, Montanari M, Lemoli R et al. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. Cancer Res 1999; 59: 3803–3811.
3. Kumagai T, Shih LY, Hughes SV, Desmond JC, O’Kelly J, Hewison M et al. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. Cancer Res 2005; 65: 2488–2497.
4. Waxman S . Differentiation therapy in acute myelogenous leukemia (non-APL). Leukemia 2000; 14: 491–496.
5. Bruserud O, Gjertsen BT . New strategies for the treatment of acute myelogenous leukemia: differentiation induction – present use and future possibilities. Stem Cells 2000; 18: 157–165.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献